Frontlight ResearchEarly access
Fabry disease trials in Argentina
1 of 2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
- Where
- Buenos Aires, Rosario
- Age
- 18 years and over
- People
- 18 worldwide
- Run by
- GC Biopharma Corp
See details and how to joinNCT06858397